10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ABBOTT LABORATORIES | ||
Ticker: ABT Fiscal Year: 2009 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2009 10-K (Filed: Feb 19, 2010) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2009 | Dec 31, 2008 | |
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 8,809,339 | 4,112,022 |
| Investments, including $307,500 of investments measured at fair value at December 31, 2007 | 1,122,709 | 967,603 |
| Trade receivables, less allowances of - 2009: $311,546; 2008: $263,632; 2007: $258,288 | 6,541,941 | 5,465,660 |
| Inventories: | ||
| Finished products | 2,289,280 | 1,545,950 |
| Work in process | 448,487 | 698,140 |
| Materials | 527,110 | 531,759 |
| Total inventories | 3,264,877 | 2,775,849 |
| Deferred income taxes | 2,364,142 | 2,462,871 |
| Other prepaid expenses and receivables | 1,210,883 | 1,258,554 |
| Total Current Assets | 23,313,891 | 17,042,559 |
| Investments | 1,132,866 | 1,073,736 |
| Property and Equipment, at Cost: | ||
| Land | 546,204 | 509,606 |
| Buildings | 4,010,439 | 3,698,861 |
| Equipment | 11,325,450 | 10,366,267 |
| Construction in progress | 604,813 | 613,939 |
| Property and Equipment, at Cost, gross | 16,486,906 | 15,188,673 |
| Less: accumulated depreciation and amortization | 8,867,417 | 7,969,507 |
| Net Property and Equipment | 7,619,489 | 7,219,166 |
| Intangible Assets, net of amortization | 6,291,989 | 5,151,106 |
| Goodwill | 13,200,174 | 9,987,361 |
| Deferred Income Taxes and Other Assets | 858,214 | 1,945,276 |
| Total Assets | 52,416,623 | 42,419,204 |
| Liabilities and Shareholders' Investment | ||
| Current Liabilities: | ||
| Short-term borrowings | 4,978,438 | 1,691,069 |
| Trade accounts payable | 1,280,542 | 1,351,436 |
| Salaries, wages and commissions | 1,117,410 | 1,011,312 |
| Other accrued liabilities | 4,363,032 | 4,216,742 |
| Dividends payable | 620,640 | 559,064 |
| Income taxes payable | 442,140 | 805,397 |
| Obligation in connection with conclusion of the TAP Pharmaceutical Products Inc. joint venture | 36,105 | 915,982 |
| Current portion of long-term debt | 211,182 | 1,040,906 |
| Total Current Liabilities | 13,049,489 | 11,591,908 |
| Long-term Debt | 11,266,294 | 8,713,327 |
| Post-employment Obligations and Other Long-term Liabilities | 5,202,111 | 4,595,278 |
| Commitments and Contingencies | ||
| Shareholders' Investment: | ||
| Preferred shares, one dollar par value Authorized - 1,000,000 shares, none issued | 0 | 0 |
| Common shares, without par value Authorized - 2,400,000,000 shares Issued at stated capital amount - Shares: 2009: 1,612,683,987; 2008: 1,601,580,899; 2007: 1,580,854,677 | 8,257,873 | 7,444,411 |
| Common shares held in treasury, at cost - Shares: 2009: 61,516,398; 2008: 49,147,968; 2007: 30,944,537 | (3,310,347) | (2,626,404) |
| Earnings employed in the business | 17,054,027 | 13,825,383 |
| Accumulated other comprehensive income (loss) | 854,074 | (1,163,839) |
| Total Abbott Shareholders' Investment | 22,855,627 | 17,479,551 |
| Noncontrolling Interests in Subsidiaries | 43,102 | 39,140 |
| Total Shareholders' Investment | 22,898,729 | 17,518,691 |
| Total Liabilities and Shareholders' Investment | 52,416,623 | 42,419,204 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |